EC
VYGR icon

EcoR1 Capital’s Voyager Therapeutics VYGR Stock Holding History

EcoR1 Capital’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,002,847
Closed -$15.7M – 40
2025
Q4 		$15.7M Buy
4,002,847
+3,332,544
+497% +$14.7M 0.71% 20
2025
Q3 		$3.13M Sell
670,303
-3,247,243
-83% -$11.7M 0.15% 28
2025
Q2 		$12.2M Hold
3,917,546
– – 0.72% 25
2025
Q1 		$13.2M Hold
3,917,546
– – 0.79% 22
2024
Q4 		$22.2M Hold
3,917,546
– – 0.84% 25
2024
Q3 		$22.9M Hold
3,917,546
– – 0.78% 30
2024
Q2 		$31M Hold
3,917,546
– – 0.95% 23
2024
Q1 		$36.5M Buy
3,917,546
+66,039
+2% +$558K 0.92% 24
2023
Q4 		$32.5M Hold
3,851,507
– – 0.84% 22
2023
Q3 		$29.8M Hold
3,851,507
– – 1.01% 19
2023
Q2 		$44.1M Hold
3,851,507
– – 1.08% 18
2023
Q1 		$29.7M Sell
3,851,507
-902,400
-19% -$7.18M 0.96% 16
2022
Q4 		$29M Hold
4,753,907
– – 0.88% 22
2022
Q3 		$28.1M Hold
4,753,907
– – 0.83% 26
2022
Q2 		$28.1M Buy
4,753,907
+1,196,400
+34% +$8.08M 0.97% 25
2022
Q1 		$27.1M Hold
3,557,507
– – 0.85% 26
2021
Q4 		$9.64M Buy
3,557,507
+3,111,515
+698% +$10.6M 0.31% 39
2021
Q3 		$1.17M Buy
+445,992
New +$1.45M 0.04% 62

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

EcoR1 Capital's VYGR Position: Q1 2026 in Review

EcoR1 Capital sold out of Voyager Therapeutics (VYGR) in Q1 2026, closing a stake of 4,002,847 shares — an estimated $15.7M sold.

EcoR1 Capital first reported a position in VYGR in Q3 2021 and held it in 18 quarters. The position peaked at $44.1M in Q2 2023. 135 funds tracked by Wall St. Rank hold VYGR as of Q1 2026.

  • EcoR1 Capital reported no remaining Voyager Therapeutics position as of Q1 2026 after selling out during the quarter.
  • EcoR1 Capital sold 4,002,847 Voyager Therapeutics shares in Q1 2026, an estimated $15.7M.
  • EcoR1 Capital first reported a position in Voyager Therapeutics in Q3 2021 and held it in 18 quarters.
  • EcoR1 Capital's Voyager Therapeutics position peaked at $44.1M in Q2 2023.
  • 135 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q1 2026.

Based on EcoR1 Capital's 13F filing for Q1 2026, filed 15 May 2026.